NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,373,197 | +572.8% | 14,351,000 | +474.0% | 0.02% | +633.3% |
Q2 2023 | $3,176,523 | -5.9% | 2,500,000 | 0.0% | 0.00% | -25.0% |
Q1 2023 | $3,376,802 | -14.9% | 2,500,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $3,970,192 | +12.2% | 2,500,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $3,540,000 | +7.0% | 2,500,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,308,000 | -93.5% | 2,500,000 | -93.5% | 0.00% | -91.7% |
Q1 2022 | $50,796,000 | +4.8% | 38,635,000 | 0.0% | 0.05% | +20.0% |
Q4 2021 | $48,457,000 | -6.1% | 38,635,000 | 0.0% | 0.04% | -14.9% |
Q3 2021 | $51,580,000 | -0.9% | 38,635,000 | -1.6% | 0.05% | +4.4% |
Q2 2021 | $52,046,000 | +667.0% | 39,270,000 | +685.4% | 0.04% | +542.9% |
Q1 2021 | $6,786,000 | -50.8% | 5,000,000 | -50.0% | 0.01% | -50.0% |
Q3 2020 | $13,805,000 | – | 10,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mint Tower Capital Management B.V. | 4,000,000 | $5,539,000 | 0.72% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,369,000 | $6,113,000 | 0.64% |
Context Capital Management, LLC | 3,000,000 | $4,169,000 | 0.57% |
CSS LLC/IL | 4,527,000 | $6,272,000 | 0.24% |
MACKAY SHIELDS LLC | 22,388,000 | $31,068,000 | 0.21% |
ADVENT CAPITAL MANAGEMENT /DE/ | 5,931,000 | $8,177,000 | 0.17% |
Calamos Advisors LLC | 21,268,000 | $29,654,000 | 0.17% |
PALISADE CAPITAL MANAGEMENT, LP | 3,600,000 | $4,986,000 | 0.13% |
LOOMIS SAYLES & CO L P | 603,276 | $57,824,000 | 0.08% |
Teton Advisors, Inc. | 337,000 | $470,000 | 0.07% |